Biden sounds a note of caution about the 'great' Pfizer news
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
You are now subscribed
Your newsletter sign-up was successful
President-elect Joe Biden said he heard the "excellent" news about Pfizer and BioNTech's promising coronavirus vaccine trial analysis last night from his public health advisers.
In a Monday morning statement, Biden — who just announced his own COVID-19 transition advisory board that will monitor the course of the pandemic between now and Biden's arrival in the White House in January — praised "the brilliant men and women who helped produce this breakthrough" that gives "us such cause for hope."
But he also urged caution, noting that if the vaccine does indeed get emergency use authorization from the Food and Drug Administration later in November, "it will be many more months before there is widespread vaccination in this country." In the meantime, Biden said Americans should still wear masks, socially distance, and practice other health and safety measures. Tim O'Donnell
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
